Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Era of Prostate Cancer Precision Medicine
Adil Malik, Srilakshmi Srinivasan, Jyotsna Batra
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics
Maria Adamaki, Vassilios Zoumpourlis
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107932-107932
Closed Access | Times Cited: 90
Biomarkers for Prostate Cancer: From Diagnosis to Treatment
Jiayan Chen, Peiyan Wang, Mingzhu Liu, et al.
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3350-3350
Open Access | Times Cited: 26
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer
Michele Signore, Romina Alfonsi, G. Federici, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 7
Open Access | Times Cited: 46
Multiparametric MRI and Machine Learning Based Radiomic Models for Preoperative Prediction of Multiple Biological Characteristics in Prostate Cancer
Xuhui Fan, Ni Xie, Jingwen Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 28
Cross‐shaped windows transformer with self‐supervised pretraining for clinically significant prostate cancer detection in bi‐parametric MRI
Yuheng Li, Jacob Wynne, Jing Wang, et al.
Medical Physics (2024) Vol. 52, Iss. 2, pp. 993-1004
Open Access | Times Cited: 7
MRI‐based prostate cancer classification using 3D efficient capsule network
Yuheng Li, Jacob Wynne, Jing Wang, et al.
Medical Physics (2024) Vol. 51, Iss. 7, pp. 4748-4758
Closed Access | Times Cited: 4
Prognostic value of PARP1 and PARP2 copy number alterations in prostate cancer
Laura Segalés, Joaquim Bellmunt, Júlia Perera-Bel, et al.
Laboratory Investigation (2025), pp. 104171-104171
Closed Access
A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
Zhi‐Bin Ke, Qi You, Jiang‐Bo Sun, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 17
New generation biomarkers for the detection of prostate cancer
Shweta J. Malode, Nagaraj P. Shetti
Biosensors and Bioelectronics X (2022) Vol. 12, pp. 100250-100250
Open Access | Times Cited: 17
Profiling of urinary extracellular vesicle protein signatures from patients with cribriform and intraductal prostate carcinoma in a cross-sectional study
Rui Bernardino, Ana Sofía Carvalho, Michael J. Hall, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective
Jiao Qu, Qianqian Liu, Guoquan You, et al.
Medicinal Research Reviews (2021) Vol. 42, Iss. 3, pp. 1147-1178
Closed Access | Times Cited: 23
Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer
Maria Adamaki, Vassilios Zoumpourlis
Cancers (2021) Vol. 13, Iss. 2, pp. 173-173
Open Access | Times Cited: 21
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1
Jessica M. Logan, Ashley M. Hopkins, Carmela Martini, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3215-3215
Open Access | Times Cited: 8
Progress of proteomics‐driven precision medicine: From a glycosylation view
Yuying Liang, Bin Fu, Ying Zhang, et al.
Rapid Communications in Mass Spectrometry (2022) Vol. 36, Iss. 10
Closed Access | Times Cited: 13
Single-cell analysis revealing the metabolic landscape of prostate cancer
Jing Wang, He-Kang Ding, Hanjiang Xu, et al.
Asian Journal of Andrology (2024) Vol. 26, Iss. 5, pp. 451-463
Open Access | Times Cited: 2
Fe-Gallic acid metal organic framework-encapsulated cellulose polymer thin film for fluorescent immunoassay of prostate-specific antigen
Sarah Alharthi, Mona N. Abou-Omar, Lamiaa Galal Amin, et al.
Results in Chemistry (2024) Vol. 10, pp. 101738-101738
Open Access | Times Cited: 2
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies
Matteo Ferro, Giuseppe Lucarelli, Ottavio De Cobelli, et al.
World Journal of Urology (2020) Vol. 39, Iss. 6, pp. 1861-1867
Open Access | Times Cited: 17
Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer
Sujun Han, Taoping Shi, Yu‐Chen Liao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology
Ioanna Maria Grypari, Vassiliki Tzelepi, Kostis Gyftopoulos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11418-11418
Open Access | Times Cited: 5
Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes
Ilona Dudka, Kristina Lundquist, Pernilla Wikström, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Claudins: New Players in Human Fertility and Reproductive System Cancers
Marta Justyna Kozieł, Karolina Kowalska, Agnieszka Wanda Piastowska‐Ciesielska
Cancers (2020) Vol. 12, Iss. 3, pp. 711-711
Open Access | Times Cited: 12
Liquid biomarkers in prostate cancer: recent advancements and future directions
Chris Ho-Ming Wong, Ivan Ching‐Ho Ko, Chi‐Fai Ng
Current Opinion in Urology (2024)
Closed Access | Times Cited: 1
PSMA-Targeted Therapy: Advancements in Detection and Treatment Modalities with Dr. Scott T. Tagawa
Viviana Cortiana, Jade Gambill, Harshal Chorya, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1833-1833
Open Access | Times Cited: 1
Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake
Nita H. Mukand, Ekaterina Chirikova, Daphne Y. Lichtensztajn, et al.
Cancer (2024) Vol. 130, Iss. 24, pp. 4298-4305
Closed Access | Times Cited: 1
Anti-prostate cancer metabolites from the soil-derived Aspergillus neoniveus
Menna Fayek, Hassan Y. Ebrahim, Heba E. Elsayed, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top